Expanded obesity drug coverage can increase Medicaid spending and put pressure on overall state budgets, and states are now facing tighter budget conditions and longer-term fiscal uncertainty, due in part to the federal Medicaid cuts in the 2025 reconciliation law, causing state Medicaid programs to re-evaluate their obesity drug coverage
Surg Obes Relat Dis 18:983996 Tronieri JS, Ghanbari E, Chevinsky J et al (2025) Anti-obesity medication for weight loss in early nonresponders to behavioral treatment: a randomized controlled trial
Drug information Related support groups Ozempic (121 questions, 240 members) Mounjaro (60 questions, 154 members) Sulfur (20 questions, 28 members) Diabetes, Type 2 (534 questions, 1,445 members) GLP-1 (29 questions, 4 members)
Consulting a knowledgeable healthcare provider before starting a new medication is strongly recommended